RxSight Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
461
- Stock Symbol
-
RXST
- Share Price
-
$5.33
- (As of Friday Closing)
RxSight General Information
Description
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
Contact Information
Website
rxsight.comCorporate Office
- 100 Columbia
- Aliso Viejo, CA 92656
- United States
Corporate Office
- 100 Columbia
- Aliso Viejo, CA 92656
- United States
RxSight Stock Performance
As of 13-Nov-2026, RxSight’s stock price is $5.33. Its current market cap is $223M with 41.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.33 | $5.38 | $4.11 - $13.22 | $223M | 41.9M | 823K | -$1.29 |
RxSight Financials Summary
As of 30-Sep-2026, RxSight has a trailing 12-month revenue of $122M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 5,588 | 212,484 | 1,159,852 | 1,317,388 |
| Revenue | 121,828 | 134,479 | 139,927 | 89,077 |
| EBITDA | (57,842) | (44,891) | (33,258) | (47,754) |
| Net Income | (53,358) | (38,944) | (27,455) | (48,608) |
| Total Assets | 340,418 | 311,814 | 318,563 | 182,550 |
| Total Debt | 10,320 | 11,040 | 12,296 | 3,012 |
RxSight Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
RxSight Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
RxSight Comparisons
Industry
Financing
Details
RxSight Competitors (20)
One of RxSight’s 20 competitors is Staar Surgical, a Corporation company based in Lake Forest, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Staar Surgical | Corporation | Lake Forest, CA | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| Philips | Corporation | Amsterdam, Netherlands | ||||
| Globus Medical | Formerly VC-backed | Audubon, PA | ||||
| The Cooper Companies | Corporation | San Ramon, CA |
RxSight Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RxSight Patents
RxSight Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260053357-A1 | Compact ultraviolet light delivery device for ophthalmic procedures | Pending | 23-Aug-2024 | ||
| US-20260053673-A1 | Compact ultraviolet light delivery device for ophthalmic procedures | Pending | 23-Aug-2024 | ||
| US-20260053674-A1 | Compact ultraviolet light delivery device for ophthalmic procedures | Pending | 23-Aug-2024 | ||
| US-20260054087-A1 | Compact ultraviolet light delivery device for ophthalmic procedures | Pending | 23-Aug-2024 | ||
| WO-2026043759-A1 | Compact ultraviolet light delivery device for ophthalmic procedures | Pending | 23-Aug-2024 | A61F2/16 |
RxSight Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
RxSight ESG
Risk Overview
Risk Rating
Updated November, 08, 2026
25.37 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Supplies
Subindustry
of 60
Rank
Percentile
RxSight FAQs
-
When was RxSight founded?
RxSight was founded in 1997.
-
Where is RxSight headquartered?
RxSight is headquartered in Aliso Viejo, CA.
-
What is the size of RxSight?
RxSight has 461 total employees.
-
What industry is RxSight in?
RxSight’s primary industry is Therapeutic Devices.
-
Is RxSight a private or public company?
RxSight is a Public company.
-
What is RxSight’s stock symbol?
The ticker symbol for RxSight is RXST.
-
What is the current stock price of RxSight?
As of 13-Nov-2026 the stock price of RxSight is $5.33.
-
What is the current market cap of RxSight?
The current market capitalization of RxSight is $223M.
-
What is RxSight’s current revenue?
The trailing twelve month revenue for RxSight is $122M.
-
Who are RxSight’s competitors?
Staar Surgical, Spine Wave, Philips, Globus Medical, and The Cooper Companies are some of the 20 competitors of RxSight.
-
What is RxSight’s annual earnings per share (EPS)?
RxSight’s EPS for 12 months was -$1.29.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
